Tower Research Capital LLC (Trc) Vincerx Pharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,989 shares of VINC stock, worth $1,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,989
Previous 7,901
11.54%
Holding current value
$1,467
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VINC
# of Institutions
28Shares Held
11MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.7MShares$567,8400.03% of portfolio
-
Prosight Management, LP Dallas, TX2.21MShares$463,3660.43% of portfolio
-
Sage Rhino Capital LLC1.7MShares$357,7160.28% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$187,2600.02% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct674KShares$141,5800.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $4.45M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...